Compounds > phentermine

phentermine and carbidopa

phentermine has been researched along with carbidopa in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Greenway, FL; Hendricks, EJ; Rothman, RB	1
Flores-Murrieta, FJ; Huerta-Cruz, JC; Lara-Padilla, E; Limón-Bernal, E; Reyes-García, JG; Roa-Coria, JE; Rocha-González, HI; Ruíz-Velasco, IRC; Zúñiga-Romero, Á	1

Reviews

1 review(s) available for phentermine and carbidopa

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

3 other study(ies) available for phentermine and carbidopa

Article	Year
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
How physician obesity specialists use drugs to treat obesity. Obesity (Silver Spring, Md.), 2009, Volume: 17, Issue:9 Topics: 5-Hydroxytryptophan; Anti-Obesity Agents; Carbidopa; Drug Combinations; Drug Labeling; Drug Therapy, Combination; Drug Utilization; Guideline Adherence; Health Care Surveys; Humans; Medicine; Obesity; Phentermine; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prescription Drugs; Retrospective Studies; Specialization; Surveys and Questionnaires; Time Factors; Treatment Outcome; United States; Weight Loss	2009
Anorectic interaction and safety of 5-hydroxytryptophan/carbidopa plus phentermine or diethylpropion in rat. Behavioural pharmacology, 2021, 08-01, Volume: 32, Issue:5 Topics: 5-Hydroxytryptophan; Animals; Appetite Depressants; Biomarkers, Pharmacological; Carbidopa; Cardiovascular System; Diethylpropion; Drug Combinations; Drug Dosage Calculations; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Obesity; Phentermine; Rats	2021